271 related articles for article (PubMed ID: 17928567)
1. Pharmacological profile of histaprodifens at four recombinant histamine H1 receptor species isoforms.
Strasser A; Striegl B; Wittmann HJ; Seifert R
J Pharmacol Exp Ther; 2008 Jan; 324(1):60-71. PubMed ID: 17928567
[TBL] [Abstract][Full Text] [Related]
2. Ligand-specific contribution of the N terminus and E2-loop to pharmacological properties of the histamine H1-receptor.
Strasser A; Wittmann HJ; Seifert R
J Pharmacol Exp Ther; 2008 Sep; 326(3):783-91. PubMed ID: 18577700
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for the selective interaction of synthetic agonists with the human histamine H1-receptor compared with the guinea pig H1-receptor.
Strasser A; Wittmann HJ; Kunze M; Elz S; Seifert R
Mol Pharmacol; 2009 Mar; 75(3):454-65. PubMed ID: 19047480
[TBL] [Abstract][Full Text] [Related]
4. Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines.
Xie SX; Ghorai P; Ye QZ; Buschauer A; Seifert R
J Pharmacol Exp Ther; 2006 Apr; 317(1):139-46. PubMed ID: 16394198
[TBL] [Abstract][Full Text] [Related]
5. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.
Deml KF; Beermann S; Neumann D; Strasser A; Seifert R
Mol Pharmacol; 2009 Nov; 76(5):1019-30. PubMed ID: 19720730
[TBL] [Abstract][Full Text] [Related]
6. Contribution of binding enthalpy and entropy to affinity of antagonist and agonist binding at human and guinea pig histamine H(1)-receptor.
Wittmann HJ; Seifert R; Strasser A
Mol Pharmacol; 2009 Jul; 76(1):25-37. PubMed ID: 19346300
[TBL] [Abstract][Full Text] [Related]
7. Influence of the N-terminus and the E2-loop onto the binding kinetics of the antagonist mepyramine and the partial agonist phenoprodifen to H(1)R.
Wittmann HJ; Seifert R; Strasser A
Biochem Pharmacol; 2011 Dec; 82(12):1910-8. PubMed ID: 21933664
[TBL] [Abstract][Full Text] [Related]
8. Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor.
Seifert R; Wenzel-Seifert K; Burckstummer T; Pertz HH; Schunack W; Dove S; Buschauer A; Elz S
J Pharmacol Exp Ther; 2003 Jun; 305(3):1104-15. PubMed ID: 12626648
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activity and ligand selectivity of human, guinea pig, rat, and canine histamine H2 receptors.
Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
J Pharmacol Exp Ther; 2007 Jun; 321(3):983-95. PubMed ID: 17332265
[TBL] [Abstract][Full Text] [Related]
10. Mutations of Cys-17 and Ala-271 in the human histamine H2 receptor determine the species selectivity of guanidine-type agonists and increase constitutive activity.
Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
J Pharmacol Exp Ther; 2007 Jun; 321(3):975-82. PubMed ID: 17347323
[TBL] [Abstract][Full Text] [Related]
11. N1-(3-cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a potent partial agonist for the human histamine H1- and H2-receptors.
Xie SX; Kraus A; Ghorai P; Ye QZ; Elz S; Buschauer A; Seifert R
J Pharmacol Exp Ther; 2006 Jun; 317(3):1262-8. PubMed ID: 16554355
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological differences between human and guinea pig histamine H1 receptors: Asn84 (2.61) as key residue within an additional binding pocket in the H1 receptor.
Bruysters M; Jongejan A; Gillard M; van de Manakker F; Bakker RA; Chatelain P; Leurs R
Mol Pharmacol; 2005 Apr; 67(4):1045-52. PubMed ID: 15626750
[TBL] [Abstract][Full Text] [Related]
13. Effects of impromidine- and arpromidine-derived guanidines on recombinant human and guinea pig histamine H1 and H2 receptors.
Xie SX; Schalkhausser F; Ye QZ; Seifert R; Buschauer A
Arch Pharm (Weinheim); 2007 Jan; 340(1):9-16. PubMed ID: 17206612
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the histamine H1-receptor binding pocket of histaprodifens.
Bruysters M; Pertz HH; Teunissen A; Bakker RA; Gillard M; Chatelain P; Schunack W; Timmerman H; Leurs R
Eur J Pharmacol; 2004 Mar; 487(1-3):55-63. PubMed ID: 15033376
[TBL] [Abstract][Full Text] [Related]
15. Striking differences of action of lisuride stereoisomers at histamine H1 receptors.
Pertz HH; Görnemann T; Schurad B; Seifert R; Strasser A
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):215-22. PubMed ID: 17106670
[TBL] [Abstract][Full Text] [Related]
16. N(alpha)-imidazolylalkyl and pyridylalkyl derivatives of histaprodifen: synthesis and in vitro evaluation of highly potent histamine H(1)-receptor agonists.
Menghin S; Pertz HH; Kramer K; Seifert R; Schunack W; Elz S
J Med Chem; 2003 Dec; 46(25):5458-70. PubMed ID: 14640554
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of specific H1-receptor agonists histaprodifen and its Nalpha-substituted analogues on bovine aortic H1-receptors.
Carman-Krzan M; Bavec A; Zorko M; Schunack W
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):538-46. PubMed ID: 12669185
[TBL] [Abstract][Full Text] [Related]
18. N (α)-Methylated phenylhistamines exhibit affinity to the hH(4)R-a pharmacological and molecular modelling study.
Wittmann HJ; Elz S; Seifert R; Straber A
Naunyn Schmiedebergs Arch Pharmacol; 2011 Sep; 384(3):287-99. PubMed ID: 21800095
[TBL] [Abstract][Full Text] [Related]
19. Structural requirements for inverse agonism and neutral antagonism of indole-, benzimidazole-, and thienopyrrole-derived histamine H4 receptor ligands.
Schneider EH; Strasser A; Thurmond RL; Seifert R
J Pharmacol Exp Ther; 2010 Aug; 334(2):513-21. PubMed ID: 20484153
[TBL] [Abstract][Full Text] [Related]
20. Side-chain modified analogues of histaprodifen: asymmetric synthesis and histamine H1-receptor activity.
Patil R; Elz S; Reiser O
Bioorg Med Chem Lett; 2006 Feb; 16(3):672-6. PubMed ID: 16266803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
